Ironwood Pharmaceuticals | IRWD - Ebit



Ironwood Pharmaceuticals reported $33.22M in EBIT for its fiscal quarter ending in December of 2024.


Ebit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Agios Pharmaceuticals USD -127056000 20.43M Jun/2025
Almirall EUR 43.02M 3.42M Jun/2025
Alnylam Pharmaceuticals USD 4.89M 13.19M Jun/2025
Amarin USD -16755000 707K Mar/2025
Ardelyx USD -12503000 20.63M Jun/2025
Astellas Pharma JPY 92.54B 137.02B Jun/2025
AstraZeneca USD 3.51B 1.3B Jun/2025
Charles River Laboratories USD 132.33M 55.89M Jun/2025
Exact Sciences USD -2148000 93.86M Jun/2025
Halozyme Therapeutics USD 202.44M 54.09M Jun/2025
Incyte USD 310.82M 27.18M Jun/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
MacroGenics USD -35344000 17.49M Jun/2025
Moderna USD -817000000 146M Jun/2025
Myriad Genetics USD -5500000 11.1M Mar/2025
Pacira USD 10.23M 2.21M Jun/2025
PTC Therapeutics USD -34858000 1.01B Jun/2025
Sarepta Therapeutics USD 115.58M 415.96M Jun/2025
Takeda JPY 257.79B 387.52B Jun/2025
Ultragenyx Pharmaceutical USD -193567000 50.63M Jun/2025